Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather A Leitch

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Blood|January 9, 2025
Iron accelerates MDS progressionHeather A Leitch
European Journal of Haematology|January 28, 2025
Iron Overload, Oxidative Stress, and Somatic Mutations in MDS: What Is the Association?Heather A Leitch
The Lancet. Haematology|April 10, 2018
Defining clinically relevant measures of iron overload around haemopoietic stem cell transplantationHeather A Leitch
The Lancet. Haematology|February 7, 2020
Idiopathic multicentric Castleman disease: bringing order to chaosHeather A Leitch
Leukemia Research|March 30, 2010
Iron chelation therapy in MDS: does it improve survival?Heather A Leitch
Blood Reviews|October 30, 2010
Controversies surrounding iron chelation therapy for MDSHeather A Leitch
Leukemia Research|August 20, 2010
Delineating parameters of iron overload in MDS patients treated with deferasiroxHeather A Leitch
Drugs|February 1, 2011
Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developmentsHeather A Leitch
Leukemia Research|December 6, 2007
Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapyHeather A Leitch
European Journal of Haematology|November 18, 2015
Hematologic improvement with iron chelation therapy in acquired anemiasHeather A Leitch
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Blood|January 9, 2025
Iron accelerates MDS progressionHeather A Leitch
European Journal of Haematology|January 28, 2025
Iron Overload, Oxidative Stress, and Somatic Mutations in MDS: What Is the Association?Heather A Leitch
The Lancet. Haematology|April 10, 2018
Defining clinically relevant measures of iron overload around haemopoietic stem cell transplantationHeather A Leitch
The Lancet. Haematology|February 7, 2020
Idiopathic multicentric Castleman disease: bringing order to chaosHeather A Leitch
Leukemia Research|March 30, 2010
Iron chelation therapy in MDS: does it improve survival?Heather A Leitch
Blood Reviews|October 30, 2010
Controversies surrounding iron chelation therapy for MDSHeather A Leitch
Leukemia Research|August 20, 2010
Delineating parameters of iron overload in MDS patients treated with deferasiroxHeather A Leitch
Drugs|February 1, 2011
Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developmentsHeather A Leitch
Leukemia Research|December 6, 2007
Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapyHeather A Leitch
European Journal of Haematology|November 18, 2015
Hematologic improvement with iron chelation therapy in acquired anemiasHeather A Leitch
Pageof 7